Literature DB >> 2298309

Peritoneal fluid and serum autoantibody levels in patients with endometriosis.

E Confino1, L Harlow, N Gleicher.   

Abstract

Patients with endometriosis demonstrate autoantibody abnormalities in their peripheral blood. Whether such abnormalities can also be detected in the peritoneal cavity, has not been established. We therefore investigated autoantibodies to 6 phospholipid antigens, 5 histones and histone subfractions and 4 polynucleotides in 14 laparoscopically diagnosed endometriosis and 9 control patients, undergoing laparoscopic tubal occlusion, in both serum and peritoneal fluid. Endometriosis patients demonstrated significantly lower total immunoglobulin G (IgG) levels in peritoneal fluid than controls. In contrast, specific IgG autoantibody levels were higher in peritoneal fluids of endometriosis patients. Mean antiphospholipids and antihistones autoantibodies reached significance when serum/peritoneal fluid ratios were compared with controls. Significant differences between endometriosis and control patients were restricted to IgG isotypes and were not observed for either IgM or IgA isotypes. These data suggest an abnormal concentration of IgG antiphospholipids and antihistones antibodies within the peritoneal cavity of endometriosis patients, which may play a contributing role in the peritoneal pathology of this condition.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2298309     DOI: 10.1016/s0015-0282(16)53274-9

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  7 in total

Review 1.  Peripheral biomarkers of endometriosis: a systematic review.

Authors:  K E May; S A Conduit-Hulbert; J Villar; S Kirtley; S H Kennedy; C M Becker
Journal:  Hum Reprod Update       Date:  2010-05-12       Impact factor: 15.610

Review 2.  The endometrial immune environment of women with endometriosis.

Authors:  Júlia Vallvé-Juanico; Sahar Houshdaran; Linda C Giudice
Journal:  Hum Reprod Update       Date:  2019-09-11       Impact factor: 15.610

Review 3.  Blood biomarkers for the non-invasive diagnosis of endometriosis.

Authors:  Vicki Nisenblat; Patrick M M Bossuyt; Rabia Shaikh; Cindy Farquhar; Vanessa Jordan; Carola S Scheffers; Ben Willem J Mol; Neil Johnson; M Louise Hull
Journal:  Cochrane Database Syst Rev       Date:  2016-05-01

4.  Antiovarian antibodies and their effect on the outcome of assisted reproduction.

Authors:  M Narayanan; P S Murthy; S A Munaf; L C Shah; M D Kini
Journal:  J Assist Reprod Genet       Date:  1995-10       Impact factor: 3.412

5.  Carrier cell-based delivery of replication-competent HSV-1 mutants enhances antitumor effect for ovarian cancer.

Authors:  S Fujiwara; A Nawa; C Luo; M Kamakura; F Goshima; C Kondo; T Kiyono; F Kikkawa; Y Nishiyama
Journal:  Cancer Gene Ther       Date:  2010-10-01       Impact factor: 5.987

6.  Diagnostic Significance of Selected Serum Inflammatory Markers in Women with Advanced Endometriosis.

Authors:  Izabela Kokot; Agnieszka Piwowar; Marcin Jędryka; Katarzyna Sołkiewicz; Ewa Maria Kratz
Journal:  Int J Mol Sci       Date:  2021-02-25       Impact factor: 5.923

Review 7.  Neuroendocrine-immune disequilibrium and endometriosis: an interdisciplinary approach.

Authors:  Nadja Tariverdian; Theoharis C Theoharides; Friederike Siedentopf; Gabriela Gutiérrez; Udo Jeschke; Gabriel A Rabinovich; Sandra M Blois; Petra C Arck
Journal:  Semin Immunopathol       Date:  2007-06       Impact factor: 9.623

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.